8.1 C
New York
Saturday, March 15, 2025
HomeHeadline newsIndian pharma company’s licence cancelled over Uzbek kids’ death

Indian pharma company’s licence cancelled over Uzbek kids’ death

Date:

Related stories

Pakistan among 41 nations facing possible US travel ban under Trump administration

A new report suggests that Pakistan, Afghanistan, and Bhutan...

Trump reverses plan for 50% per cent tariffs on Canadian steel and aluminum

Trump Reverses Course on 50% Tariffs for Canadian Metals US...

Ukraine posts subtle hint with ‘handshake emoji’ regarding the progress with US relations

High-level diplomatic talks between the United States and Ukraine...

Indian Americans favor Biden’s India policy over Trump’s, survey reveals

A recent survey conducted by the Carnegie Endowment for...

India has cancelled the manufacturing licence of Noida-based pharmaceutical firm Marion Biotech, according to officials.

Marion Biotech’s cough syrup Dok-1 was linked with the death of 18 children in Uzbekistan. The incident which occurred last December prompted India’s federal and Uttar Pradesh state drug authorities to launch a probe into the matter.

“The firm’s licence was under suspension since January after which a detailed inquiry was initiated. Now the licence of the firm has been cancelled by the Uttar Pradesh Drugs Controlling and Licensing Authority. The firm can no longer manufacture the syrup,” a government official said on Wednesday (22).

On March 3, the Noida Police arrested three employees of Marion from its office while a lookout notice was issued for two of its directors after a first information report (FIR) was lodged against all of them, the official said.

The FIR had come in the wake of investigations finding that samples of Marion Biotech’s drugs were “adulterated” and “not of standard quality.”

- Advertisement -

The samples were sent to the regional drug testing laboratory in Chandigarh and 22 of them were found to be ‘not of standard quality’ (adulterated and spurious), according to the FIR.

On January 12, the World Health Organization (WHO) had issued a ‘medical product alert’, referring to two substandard (contaminated) products, identified in Uzbekistan.

“The two products are Ambronol syrup and DOK-1 Max syrup… Laboratory analysis of samples of both products, undertaken by national quality control laboratories of the Ministry of Health of the Republic of Uzbekistan found both products contained unacceptable amounts of diethylene glycol and/or ethylene glycol as contaminants,” it had noted.

(PTI)

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories